1.08
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CTSO Giù?
Forum
Previsione
Frazionamento azionario
Cytosorbents Corp Borsa (CTSO) Ultime notizie
Technical signs of recovery in Cytosorbents Corporation2025 Macro Impact & Step-by-Step Trade Execution Guides - Newser
Why Cytosorbents Corporation stock attracts strong analyst attention2025 Technical Overview & Weekly High Return Forecasts - Newser
What recovery options are there for Cytosorbents CorporationRisk Management & Technical Pattern Based Buy Signals - Newser
How sentiment analysis helps forecast Cytosorbents CorporationQuarterly Portfolio Report & Long-Term Safe Return Strategies - Newser
Is now a turning point for Cytosorbents Corporation2025 Biggest Moves & Daily Stock Trend Watchlist - Newser
Cytosorbents Corp Q2 2025 Earnings Call Highlights - TipRanks
Published on: 2025-08-12 20:31:12 - Newser
Sector ETF performance correlation with Cytosorbents Corporation [July 2025 Drop Watch]Risk Controlled Swing Trade Alerts - Newser
Is this a good reentry point in Cytosorbents CorporationFree Daily Chart Pattern Stock Forecast - Newser
Is Cytosorbents Corporation reversing from oversold territoryForecast Model for Intraday Buy Signals - Newser
Cytosorbents Corporation (NASDAQ:CTSO) Q2 2025 Earnings Call Transcript - Insider Monkey
Exit strategy if you’re trapped in Cytosorbents CorporationEquity Market Return Forecast Model Update - Newser
Can volume confirm reversal in Cytosorbents CorporationExit Strategy Guide With Risk Control Plan - Newser
What institutions are buying Cytosorbents Corporation stock now5-Year Price Trend Summary and Analysis - Newser
Will Cytosorbents Corporation continue its uptrendFree Long Hold Safe Return Strategy - Newser
Cytosorbents’ (CTSO) “Buy” Rating Reiterated at D. Boral Capital - Defense World
Cytosorbents Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
How to forecast Cytosorbents Corporation trends using time seriesHigh Return Strategy with Low Risk - Newser
How Cytosorbents Corporation stock performs during market volatilityTechnical Screener for High Growth Stocks - Newser
Earnings call transcript: CytoSorbents Q2 2025 revenue miss, stock dips By Investing.com - Investing.com Canada
Earnings call transcript: CytoSorbents Q2 2025 revenue miss, stock dips - Investing.com
CytoSorbents Corp (CTSO) Q2 2025 Earnings Call Highlights: Strat - GuruFocus
CytoSorbents Reports Positive Q2 2025 Financial Results - TipRanks
Cytosorbents Corp reports results for the quarter ended June 30Earnings Summary - TradingView
CytoSorbents: Q2 Earnings Snapshot - San Antonio Express-News
CytoSorbents Reports Second Quarter 2025 Financial Results and Provides Business Update - PR Newswire
Reversal indicators forming on Cytosorbents Corporation stockFree Wealth Building Stock Market Ideas - Newser
What MACD signals say about Cytosorbents CorporationWeekly Market Direction and Sector Summary - Newser
Cytosorbents Corp expected to post a loss of 5 cents a shareEarnings Preview - TradingView
How to recover losses in Cytosorbents Corporation stockBuy and Hold Return Summary with Charts - Newser
Tools to assess Cytosorbents Corporation’s risk profileFree Real Time Alerts Based on AI Prediction - Newser
Is Cytosorbents Corporation stock overvalued or undervaluedAchieve rapid portfolio growth with expert guidance - Jammu Links News
Is it the right time to buy Cytosorbents Corporation stockBuild a portfolio that delivers consistent profits - Jammu Links News
Breakthrough Sepsis Treatment: CytoSorb Therapy Achieves 70% Survival Rate in Latest Clinical Studies - Stock Titan
CytoSorbents Leads a New Era in Sepsis Treatment - Nasdaq
What makes Cytosorbents Corporation stock price move sharplyWeekly High Conviction Trade Setup Analysis - Newser
Should you wait for a breakout in Cytosorbents CorporationFree Wealth Building Stock Market Ideas - Newser
Medical Tech Leader CytoSorbents Sets Q2 2025 Earnings Call: Key Updates Expected on ICU Treatment Solutions - Stock Titan
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):